It did not reduce maternal bile acid concentrations, and the reduction in alanine transaminase was of uncertain clinical significance, given that alanine transaminase is not known to be associated with the risk of stillbirth or preterm labor in intrahepatic cholestasis of pregnancy. The gene discussed is GPT; the disease is intrahepatic cholestasis.